The U.S. Food and Drug Administration approved the Wegovy pill in late December 2025 for adults who are obese or overweight ...

The Wegovy pill is only available in the U.S. with a doctor’s prescription. Patients can pick it up at pharmacies nationwide, ...

FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo ...

Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for ...

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...

The lowest doses of the daily pill will cost $149 a month for people paying out of pocket, offering a cheaper alternative to ...

The Wegovy pill is now available in the starting dose at pharmacies and telehealth platforms nationally, opening a new phase ...

Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...

Novo Nordisk is the first manufacturer to market its drug Wegovy in pill form in the U.S., though Eli Lilly expects approval ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?